 |
Tony Fong is senior editor for GenomeWeb Daily News, tracking the firms that compete in the genomics tools and molecular diagnostics industries. E-mail Tony Fong or follow GWDN's headlines at @DailyNewsGW. |
Prostate Cancer MDx Firm GenomeDx to Launch First Test This Year
January 18, 2013
Prostate Cancer MDx Firm GenomeDx to Launch First Test This Year
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- GenomeDx Presents Data on Prostate Cancer Test's Prognostic Performance, Impact on Treatment
February 20, 2013 / Pharmacogenomics Reporter - Idaho Tech Preparing for Regulatory Clearance, Launch of Blood Culture ID, GI Panels
August 2, 2012 / GenomeWeb Daily News - Signature Dx to Use Affymetrix Chips for Cancer Test Development
June 28, 2010 / GenomeWeb Daily News - GenomeDx, Mayo Clinic Expand Research Deal
April 29, 2013 / GenomeWeb Daily News - Grifols Acquires 60 Percent Stake in Progenika
March 7, 2013 / GenomeWeb Daily News